caveolin-2 Inhibitors

The chemical class of Caveolin-2 Inhibitors includes a range of compounds that can potentially suppress or modulate the expression and activity of Caveolin-2, primarily through effects on cholesterol metabolism, kinase activity, and cellular signaling. Cholesterol-lowering statins like Atorvastatin and Lovastatin, cholesterol-extracting compounds like Methyl-β-cyclodextrin and Filipin, and kinase inhibitors such as Genistein, Roscovitine, Dasatinib, and Gefitinib are included due to their roles in altering membrane dynamics and signaling pathways.

Nystatin, which alters membrane cholesterol, and 2-Bromopalmitate, a palmitoylation inhibitor, could impact Caveolin-2 by influencing post-translational modifications and membrane structure. Sodium Nitroprusside, as a nitric oxide donor, and Everolimus, an mTOR inhibitor, are considered for their potential to modulate various cellular processes and signaling pathways related to Caveolin-2.